When Is Prevention More Profitable than Cure? The Impact of Time-Varying Consumer Heterogeneity
Year of publication: |
2013-03
|
---|---|
Authors: | Kremer, Michael ; Snyder, Christopher M. |
Institutions: | National Bureau of Economic Research (NBER) |
Extent: | application/pdf |
---|---|
Series: | |
Type of publication: | Book / Working Paper |
Notes: | EFG HC The price is Paper copy available by mail Number 18862 |
Classification: | D42 - Monopoly ; I18 - Government Policy; Regulation; Public Health ; L11 - Production, Pricing, and Market Structure Size; Size Distribution of Firms ; O31 - Innovation and Invention: Processes and Incentives |
Source: |
-
Sauer, Robert M., (2014)
-
Kremer, Michael, (2013)
-
When is Prevention More Profitable than Cure? The Impact of Time-Varying Consumer Heterogeneity
Kremer, Michael, (2013)
- More ...
-
Why Are Drugs More Profitable Than Vaccines?
Kremer, Michael, (2003)
-
Strengthening incentives for vaccine development
Kremer, Michael, (2020)
-
Kremer, Michael, (2015)
- More ...